Evidence map›Paper›PMID 40853573›Full record

ArticleBiodegradation2025

Prodigious biodegradation of polycyclic aromatic fluorene with manganese oxide nanoparticles from Stenotrophomonas sp.

Ayesha Aseef, S Venkat Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Biodegradation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ayesha AseefDepartment of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, 632104, India.
S Venkat KumarDepartment of Integrative Biology, School of Biosciences and Technology, Vellore Institute of Technology (VIT), Vellore, 632104, India. venkatkumars@vit.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current research explores the microbial synthesis of manganese oxide nanoparticles from Stenotrophomonas sp. their characterization, and subsequent application against the degradation of fluorene hydrocarbon. There are several physical and chemical strategies to treat polycyclic aromatic hydrocarbons. But Nano-bioremediation is most effective and economical in degrading the polycyclic aromatic hydrocarbons. Various structural, crystalline, and optical characteristics of manganese oxide nanoparticles were investigated. Manganese oxide nanoparticle formation is indicated by a distinctive peak at 248 nm with a 3.5 eV band gap. X-ray diffraction demonstrated that manganese oxide nanoparticles had a crystalline grain size of 6.3 nm. Scanning and high-resolution transmission electron micrographs reveal the agglomerated spherical form. Manganese and oxygen existence and purity were validated with EDAX analysis. This study investigated the optimizational degradation of fluorene hydrocarbon using response surface methodology. The degradation of fluorene hydrocarbon was examined using Fourier Transform Infrared Spectroscopy and Gas chromatography-mass spectrometric analysis. Trigonella foenum-graecum was used in the phyto-toxicity study of fluorene degradation by microbial-synthesized manganese oxide nanoparticles.

Indexed as

FluorenesManganese CompoundsNanoparticlesOxidesPolycyclic Aromatic HydrocarbonsStenotrophomonasBiodegradation, EnvironmentalSpectroscopy, Fourier Transform InfraredX-Ray DiffractionfluoreneFluorenesManganese Compoundsmanganese oxideOxidesPolycyclic Aromatic HydrocarbonsManganese oxide nanoparticlesNano-bioremediationResponse surface methodologyStenotrophomonas spTrigonella foenum-graecum

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.